For condition: Psoriasis
Adults Psoriasis Study (2 Months)
Study Summary
Who Can Participate?
Adults with moderate to severe plaque psoriasis may participate.
Inclusion Criteria
- Moderate-to-severe plaque psoriasis adult patients who are candidates for certain advanced treatments, known as biologic disease-modifying antirheumatic drugs (bDMARDs) as per provincial reimbursement criteria
- Residents of Canada
What Are The Benefits?
- No cost to participate
- Regular visits with study doctors who specialise in treating psoriatic disease (or psoriasis and psoriatic arthritis) as there is one visit at the Dermatologist, one visit at the Rheumatologist and a phone call from the Dermatologist.
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- 10 weeks
For more information about this trial, please visit ClinicalTrials.gov
